Targeting IL-β pathway for cancer immunotherapy

被引：4

作者：

Jayaraman, Pushpa ^{[1
]}

Millholland, John ^{[2
]}

O'Brien, Neil ^{[3
]}

Wong, Connie ^{[2
]}

Diwanji, Rohan ^{[1
]}

Wang, Muchun ^{[1
]}

Choi, Elizabeth ^{[1
]}

Linnartz, Ronald ^{[4
]}

Rose, Kristine ^{[4
]}

Rodrik-Outmezguine, Vanessa ^{[4
]}

Pelletier, Marc ^{[5
]}

Savchenko, Alexander ^{[1
]}

Luo, Tong ^{[3
]}

Rezek, Valerie ^{[3
]}

Kitchen, Scott ^{[3
]}

Baum, Jason ^{[2
]}

Sabatos-Peyton, Catherine ^{[1
]}

Martin, Anne-Marie ^{[4
]}

Dranoff, Glenn ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Exploratory Immuno Oncol, Cambridge, MA USA

[2] Novartis, Oncol Precis Med, Cambridge, MA USA

[3] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA

[4] Novartis, Oncol Precis Med, E Hanover, NJ USA

[5] Novartis Inst Biomed Res, Oncol Translat Res, Cambridge, MA USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2019年 / 18卷 / 12期

关键词：

D O I：

10.1158/1535-7163.TARG-19-C103

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

C103

引用

页数：3

共 50 条

[21] EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy [J].

Kang, James J. ;

Ko, Albert ;

Kil, Sang Hoon ;

Clair, Jon Mallen-St. ;

Shin, Daniel Sanghoon ;

Wang, Marilene B. ;

Srivatsan, Eri S. .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (01)

[22] Targeting the adenosine immunosuppressive pathway for cancer immunotherapy with small molecule agents [J].

Fons, Pierre ;

Esquerre, Michael ;

Versluys, Stephanie ;

Mambrini, Gigliola ;

Paillasse, Michael ;

Bell, Andy ;

Schreyer, Adrian ;

Cox, Richard ;

Bickerton, Richard ;

Lisztwan, Joanna ;

Whittaker, Mark ;

Bono, Francoise ;

Johnstone, Craig ;

Hopkins, Andrew .

CANCER RESEARCH, 2017, 77

[23] Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy [J].

Thibodeau, Jacques ;

Bourgeois-Daigneault, Marie-Claude ;

Lapointe, Rejean .

ONCOIMMUNOLOGY, 2012, 1 (06) :908-916

[24] Targeting the hippo pathway as a potential regulator of immune checkpoints in cancer immunotherapy [J].

Meng, Yu-ying ;

Chang, Xin ;

Cao, Si-si ;

Ma, Ping ;

Yi, Ou-yang ;

Dong, Min .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 161

[25] Targeting the IDO1-Kynurenine-AhR pathway for cancer immunotherapy [J].

Pinto, Sheena ;

Steeneck, Christoph ;

Albers, Michael ;

Anderhub, Simon ;

Birkel, Manfred ;

Buselic-Woelfel, Larisa ;

Eisenhardt, Gisela ;

Kremoser, Claus ;

Hoffmann, Thomas ;

Deuschle, Ulrich .

CANCER RESEARCH, 2019, 79 (13)

[26] New perspectives in cancer immunotherapy: targeting IL-6 cytokine family [J].

Soler, Maria Florencia ;

Abaurrea, Andrea ;

Azcoaga, Peio ;

Araujo, Angela M. ;

Caffarel, Maria M. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (11)

[27] From allergy to oncology: Targeting IL-4 to boost cancer immunotherapy [J].

Consonni, Filippo ;

Corsello, Antonio ;

Pegoraro, Francesco .

ALLERGY, 2024, 79 (10) :2890-2892

[28] Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7 [J].

Kim, Ji-Hae ;

Lee, Kun-Joo ;

Lee, Seung-Woo .

BMB REPORTS, 2021, 54 (01) :21-30

[29] Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer [J].

Sitkovsky, Michail ;

Ohta, Akio .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (02) :147-155

[30] Targeting the LIFR-LCN2 pathway to sensitize liver cancer to immunotherapy [J].

Deng, Yalan ;

Ma, Li .

CANCER RESEARCH, 2024, 84 (06)

← 1 2 3 4 5 →